Melanoma treatment mystery gets new answers from mathematical model
New research from the University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, despite promising laboratory studies of intermittent dosing.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.